NCT01945788View on ClinicalTrials.gov

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

PHASE4UnknownINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions

Postmenopausal Osteoporosis With Pathological Fracture

Interventions

DRUG

Teriparatide (rDNA origin)

Trial Locations (1)

Unknown

Instituto de Investigaciones Metabolicas, Buenos Aires

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bio Sidus SA

INDUSTRY